About the Hemostasis and Thrombosis Center
The Hemostasis and Thrombosis Center (HTC) at Children’s Hospital of Philadelphia (CHOP) provides comprehensive care to children and adolescents with hemophilia and other inherited bleeding disorders. The center also treats children with blood clots (thrombosis) or who are at increased risk for blood clots (thrombophilia).
At CHOP, our multidisciplinary team works to ensure that patients with inherited bleeding or clotting disorders and their families have access to appropriate hematologic, genetic, and other medical expertise. Our medical home model provides family-centered, culturally competent and quality comprehensive care.
Education, counseling and testing
From the time of diagnosis, our team works with your child and family to provide appropriate education, counseling and testing. We also help develop an individualized care plan that meets your entire family’s needs.
Communication is a critical part of the delivery of safe and effective care at the HTC at CHOP. We encourage you to ask questions and provide feedback. We are available 24 hours a day, 7 days a week to assist with any acute issues your child may develop.
50 years of providing care
In 2023, the Hemostasis and Thrombosis Center (HTC) at Children’s Hospital of Philadelphia (CHOP) is proudly celebrating 50 years of providing comprehensive care to children and adolescents with hemophilia and other inherited bleeding or clotting disorders.
Collaboration at a national level
The HTC at CHOP is a part of the national network of federally funded HTCs in the U.S. and previously served as the Core Center for the 16 HTCs in the Mid-Atlantic Region, 15 years under the leadership of Regina Butler, RN-BC. As a Core Center, CHOP oversaw the services provided by the Mid-Atlantic Region III HTCs and collaborated with the Maternal and Child Health Bureau and CDC to improve treatment and support for people with hemophilia and other inherited bleeding and clotting disorders. The Core Center has been transferred to Lehigh Valley Hospital.
Together, we have successfully collaborated in the evaluation and implementation of expert services and serve as a national resource on bleeding and clotting disorders.